{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:34:34Z","timestamp":1781123674142,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009606","name":"Arabian Gulf University, Bahrain","doi-asserted-by":"crossref","award":["G2 \u2012AGU\u2012 11\u201223"],"award-info":[{"award-number":["G2 \u2012AGU\u2012 11\u201223"]}],"id":[{"id":"10.13039\/100009606","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009606","name":"Arabian Gulf University, Bahrain","doi-asserted-by":"crossref","award":["G2 \u2012AGU\u2012 11\u201223"],"award-info":[{"award-number":["G2 \u2012AGU\u2012 11\u201223"]}],"id":[{"id":"10.13039\/100009606","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009606","name":"Arabian Gulf University, Bahrain","doi-asserted-by":"crossref","award":["G2 \u2012AGU\u2012 11\u201223"],"award-info":[{"award-number":["G2 \u2012AGU\u2012 11\u201223"]}],"id":[{"id":"10.13039\/100009606","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Salmanya Medical Complex, Bahrain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39385-8","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T13:14:58Z","timestamp":1770556498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["STYK1 expression in breast cancer and its association with vascular invasion and clinicopathological features"],"prefix":"10.1038","volume":"16","author":[{"given":"Rabab","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Ismaeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Alshaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aalaa","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajedah","family":"Sabt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samvel","family":"Selvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"39385_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.breast.2011.04.002","volume":"20","author":"SJ Storr","year":"2011","unstructured":"Storr, S. J. et al. Calpastatin is associated with lymphovascular invasion in breast cancer. Breast 20, 413\u2013418. https:\/\/doi.org\/10.1016\/j.breast.2011.04.002 (2011).","journal-title":"Breast"},{"key":"39385_CR2","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1038\/sj.onc.1203957","volume":"19","author":"DR Robinson","year":"2000","unstructured":"Robinson, D. R., Wu, Y. M. & Lin, S. F. The protein tyrosine kinase family of the human genome. Oncogene 19, 5548\u20135557. https:\/\/doi.org\/10.1038\/sj.onc.1203957 (2000).","journal-title":"Oncogene"},{"key":"39385_CR3","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1158\/0008-5472.CAN-03-2106","volume":"64","author":"L Liu","year":"2004","unstructured":"Liu, L. et al. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor\/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice. Cancer Res. 64, 3491\u20133499. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-2106 (2004).","journal-title":"Cancer Res."},{"key":"39385_CR4","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.26355\/eurrev_202006_21512","volume":"24","author":"XL Li","year":"2020","unstructured":"Li, X. L., Huang, Y. Y., Yuan, T. J., Lian, X. P. & Bi, H. L. STYK1 promotes the malignant progression of laryngeal squamous cell carcinoma through targeting TGF-beta1. Eur. Rev. Med. Pharmacol. Sci. 24, 6166\u20136174. https:\/\/doi.org\/10.26355\/eurrev_202006_21512 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"39385_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12935-021-02114-4","volume":"21","author":"R Dai","year":"2021","unstructured":"Dai, R. et al. Lnc-STYK1-2 regulates bladder cancer cell proliferation, migration, and invasion by targeting miR-146b-5p expression and AKT\/STAT3\/NF-kB signaling. Cancer Cell. Int. 21, 408. https:\/\/doi.org\/10.1186\/s12935-021-02114-4 (2021).","journal-title":"Cancer Cell. Int."},{"key":"39385_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biocel.2018.01.016","volume":"97","author":"YP Hu","year":"2018","unstructured":"Hu, Y. P. et al. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma. Int. J. Biochem. Cell. Biol. 97, 16\u201327. https:\/\/doi.org\/10.1016\/j.biocel.2018.01.016 (2018).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"39385_CR7","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.7314\/apjcp.2014.15.16.6685","volume":"15","author":"AV Orang","year":"2014","unstructured":"Orang, A. V., Safaralizadeh, R., Hosseinpour Feizi, M. A. & Somi, M. H. Diagnostic relevance of overexpressed Serine threonine tyrosine kinase\/novel oncogene with kinase domain (STYK1\/ NOK) mRNA in colorectal cancer. Asian Pac. J. Cancer Prev. 15, 6685\u20136689. https:\/\/doi.org\/10.7314\/apjcp.2014.15.16.6685 (2014).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"39385_CR8","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.2147\/CMAR.S181910","volume":"10","author":"J Fang","year":"2018","unstructured":"Fang, J. et al. Low STYK1 expression indicates poor prognosis in gastric cancer. Cancer Manag Res. 10, 6669\u20136676. https:\/\/doi.org\/10.2147\/CMAR.S181910 (2018).","journal-title":"Cancer Manag Res."},{"key":"39385_CR9","first-page":"4969","volume":"26","author":"R Moriai","year":"2006","unstructured":"Moriai, R., Kobayashi, D., Amachika, T., Tsuji, N. & Watanabe, N. Diagnostic relevance of overexpressed NOK mRNA in breast cancer. Anticancer Res. 26, 4969\u20134973 (2006).","journal-title":"Anticancer Res."},{"key":"39385_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11033-006-9047-1","volume":"35","author":"KS Kimbro","year":"2008","unstructured":"Kimbro, K. S., Duschene, K., Willard, M., Moore, J. A. & Freeman, S. A novel gene STYK1\/NOK is upregulated in Estrogen receptor-alpha negative Estrogen receptor-beta positive breast cancer cells following Estrogen treatment. Mol. Biol. Rep. 35, 23\u201327. https:\/\/doi.org\/10.1007\/s11033-006-9047-1 (2008).","journal-title":"Mol. Biol. Rep."},{"key":"39385_CR11","doi-asserted-by":"publisher","DOI":"10.1101\/2024.08.14.608018","author":"Yinyin Wang","year":"2024","unstructured":"Yinyin Wang et al. NOK promotes tumorigenesis through coordinating epidermal growth factor receptor to boost the downstream signaling in breast cancer. BioRxiv https:\/\/doi.org\/10.1101\/2024.08.14.608018 (2024).","journal-title":"BioRxiv"},{"key":"39385_CR12","doi-asserted-by":"publisher","first-page":"111333","DOI":"10.18632\/oncotarget.22794","volume":"8","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients. Oncotarget 8, 111333\u2013111345. https:\/\/doi.org\/10.18632\/oncotarget.22794 (2017).","journal-title":"Oncotarget"},{"key":"39385_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1471-2407-14-402","volume":"14","author":"P Chen","year":"2014","unstructured":"Chen, P. et al. Clinicopathologic features and prognostic implications of NOK\/STYK1 protein expression in non-small cell lung cancer. BMC Cancer. 14, 402. https:\/\/doi.org\/10.1186\/1471-2407-14-402 (2014).","journal-title":"BMC Cancer"},{"key":"39385_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.lungcan.2007.01.002","volume":"56","author":"T Amachika","year":"2007","unstructured":"Amachika, T., Kobayashi, D., Moriai, R., Tsuji, N. & Watanabe, N. Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancers. Lung Cancer. 56, 337\u2013340. https:\/\/doi.org\/10.1016\/j.lungcan.2007.01.002 (2007).","journal-title":"Lung Cancer"},{"key":"39385_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7754\/clin.lab.2015.150626","volume":"62","author":"Q Cao","year":"2016","unstructured":"Cao, Q. et al. High novel oncogene with Kinase-Domain (NOK) gene expression is associated with the progression of renal cell carcinoma. Clin. Lab. 62, 179\u2013186. https:\/\/doi.org\/10.7754\/clin.lab.2015.150626 (2016).","journal-title":"Clin. Lab."},{"key":"39385_CR16","doi-asserted-by":"publisher","first-page":"101709","DOI":"10.1016\/j.bbrep.2024.101709","volume":"38","author":"Y Yang","year":"2024","unstructured":"Yang, Y., Liu, L. & Tucker, H. O. The malignant transformation potential of the oncogene STYK1\/NOK at early lymphocyte development in Transgenic mice. Biochem. Biophys. Rep. 38, 101709. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101709 (2024).","journal-title":"Biochem. Biophys. Rep."},{"key":"39385_CR17","doi-asserted-by":"publisher","first-page":"14173","DOI":"10.1007\/s13277-016-5188-6","volume":"37","author":"MY Chen","year":"2016","unstructured":"Chen, M. Y. et al. Depletion of STYK1 inhibits intrahepatic cholangiocarcinoma development both in vitro and in vivo. Tumour Biol. 37, 14173\u201314181. https:\/\/doi.org\/10.1007\/s13277-016-5188-6 (2016).","journal-title":"Tumour Biol."},{"key":"39385_CR18","doi-asserted-by":"publisher","unstructured":"Zeng, S. L. et al. STYK1\/NOK affects cell cycle late mitosis and directly interacts with anaphase-promoting complex activator CDH1. Heliyon 8, e12058. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12058 (2022).","DOI":"10.1016\/j.heliyon.2022.e12058"},{"key":"39385_CR19","doi-asserted-by":"publisher","unstructured":"Cicenas, J., Zalyte, E., Bairoch, A. & Gaudet, P. Kinases and cancer. Cancers (Basel). 10 https:\/\/doi.org\/10.3390\/cancers10030063 (2018).","DOI":"10.3390\/cancers10030063"},{"key":"39385_CR20","doi-asserted-by":"publisher","first-page":"100045","DOI":"10.1016\/j.cellin.2022.100045","volume":"1","author":"C Zhou","year":"2022","unstructured":"Zhou, C. et al. Phosphorylated STYK1 restrains the inhibitory role of EGFR in autophagy initiation and EGFR-TKIs sensitivity. Cell. Insight. 1, 100045. https:\/\/doi.org\/10.1016\/j.cellin.2022.100045 (2022).","journal-title":"Cell. Insight"},{"key":"39385_CR21","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1080\/15548627.2019.1687212","volume":"16","author":"C Zhou","year":"2020","unstructured":"Zhou, C. et al. STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I. Autophagy 16, 1786\u20131806. https:\/\/doi.org\/10.1080\/15548627.2019.1687212 (2020).","journal-title":"Autophagy"},{"key":"39385_CR22","doi-asserted-by":"publisher","first-page":"621147","DOI":"10.3389\/fcell.2021.621147","volume":"9","author":"Y Lai","year":"2021","unstructured":"Lai, Y. et al. STYK1\/NOK promotes metastasis and Epithelial-Mesenchymal transition in Non-small cell lung cancer by suppressing FoxO1 signaling. Front. Cell. Dev. Biol. 9, 621147. https:\/\/doi.org\/10.3389\/fcell.2021.621147 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"39385_CR23","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1111\/j.1349-7006.2009.01277.x","volume":"100","author":"S Chung","year":"2009","unstructured":"Chung, S. et al. Overexpression of the potential kinase serine\/ threonine\/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer. Cancer Sci. 100, 2109\u20132114. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01277.x (2009).","journal-title":"Cancer Sci."},{"key":"39385_CR24","doi-asserted-by":"publisher","first-page":"33205","DOI":"10.1038\/srep33205","volume":"6","author":"Z Wang","year":"2016","unstructured":"Wang, Z. et al. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK\/ERK and PI3K\/AKT signaling. Sci. Rep. 6, 33205. https:\/\/doi.org\/10.1038\/srep33205 (2016).","journal-title":"Sci. Rep."},{"key":"39385_CR25","doi-asserted-by":"publisher","first-page":"10299","DOI":"10.2147\/OTT.S210014","volume":"12","author":"Z Huang","year":"2019","unstructured":"Huang, Z. et al. Aberrantly high expression of NOK\/STYK1 is tightly associated with the activation of the AKT\/GSK3beta\/N-Cadherin pathway in Non-Small cell lung cancer. Onco Targets Ther. 12, 10299\u201310309. https:\/\/doi.org\/10.2147\/OTT.S210014 (2019).","journal-title":"Onco Targets Ther."},{"key":"39385_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbrc.2016.07.059","volume":"478","author":"Y Liu","year":"2016","unstructured":"Liu, Y., Li, T., Hu, D. & Zhang, S. NOK\/STYK1 promotes the genesis and remodeling of blood and lymphatic vessels during tumor progression. Biochem. Biophys. Res. Commun. 478, 254\u2013259. https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.059 (2016).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39385-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:45:46Z","timestamp":1772192746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39385-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39385"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39385-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7775"}}